POVTENZI

Serial Number 99250865
688

Registration Progress

Application Filed
Jun 24, 2025
Under Examination
Oct 14, 2025
Approved for Publication
Aug 19, 2025
Published for Opposition
Aug 19, 2025
Registered

Trademark Image

POVTENZI

Basic Information

Serial Number
99250865
Filing Date
June 24, 2025
Published for Opposition
August 19, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Oct 14, 2025
Application
Pending
Classes
005

Rights Holder

Vertex Pharmaceuticals Incorporated

03
Address
50 Northern Avenue
Boston, MA 02210

Ownership History

Vertex Pharmaceuticals Incorporated

Original Applicant
03
Boston, MA

Vertex Pharmaceuticals Incorporated

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Lisa M. Tittemore

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

9 events
Date Code Type Description Documents
Oct 14, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 19, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 19, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 13, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 14, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 10, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 24, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jun 24, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 24, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders

Classification

International Classes
005